Antibiotic Selection for Suspected Bacterial Infections

Context-Specific Antibiotic Selection

The National Institute for Health and Care Excellence (NICE) recommends benzylpenicillin plus gentamicin as first-line treatment for early-onset neonatal sepsis (first 72 hours) 1
For suspected sepsis in neonates up to 3 months, NICE guideline 51 (2016) recommends ceftriaxone with ampicillin/amoxicillin 2
For animal bites, the American Academy of Otolaryngology-Head and Neck Surgery recommends oral treatment with amoxicillin-clavulanate (co-amoxiclav) 3, 4
For acute bacterial rhinosinusitis in adults with mild disease, the American Academy of Otolaryngology-Head and Neck Surgery recommends amoxicillin-clavulanate (1.75-4 g/250 mg per day), cefuroxime axetil, or cefdinir as initial choices 5
For pandemic influenza with bacterial superinfection, the Journal of Infection recommends a fluoroquinolone with enhanced pneumococcal activity plus broad-spectrum beta-lactamase stable antibiotic, or a macrolide 6

High-risk patients (prolonged neutropenia >7 days, ANC <100 cells/mm³, hypotension, pneumonia) require hospitalization with IV monotherapy using anti-pseudomonal beta-lactams, according to the Infectious Diseases Society of America 7
Adults who received antibiotics in the previous 4-6 weeks should be considered for respiratory fluoroquinolones or high-dose amoxicillin-clavulanate (4 g/250 mg per day) rather than standard regimens, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 5

Patients with immediate-type hypersensitivity (hives, bronchospasm) should avoid all beta-lactams and carbapenems; instead, use ciprofloxacin plus clindamycin or aztreonam plus vancomycin, as recommended by the Infectious Diseases Society of America 7
Most penicillin-allergic patients tolerate cephalosporins if there is no immediate hypersensitivity history, according to the Infectious Diseases Society of America 7

In the context of COVID-19, NICE states that antibiotics should NOT be prescribed if COVID-19 is the likely cause of respiratory illness unless bacterial superinfection is suspected 8
The World Health Organization recommends against empiric antibiotics in mild COVID-19 8

Switch to oral therapy when clinical improvement occurs and temperature is normal for 24 hours, as recommended by the Journal of Infection 6
Most non-severe pneumonia requires 7 days of appropriate antibiotics, according to the Journal of Infection 6
Severe pneumonia requires 10 days, extended to 14-21 days for S. aureus or gram-negative enteric bacilli, as recommended by the Journal of Infection 6

Vancomycin is NOT recommended as standard initial therapy for fever and neutropenia, according to the Infectious Diseases Society of America 7
Add MRSA coverage only for specific indications: suspected catheter-related infection, skin/soft-tissue infection, pneumonia, or hemodynamic instability, as recommended by the Infectious Diseases Society of America 7
Patients hospitalized within recent months have a higher MRSA carriage risk, according to the Journal of Infection 6

Obtain blood cultures (at least 2 sets) and other relevant cultures BEFORE starting antibiotics, as recommended by the Infectious Diseases Society of America 7
Reassess at 72 hours; if no response, consider resistant organisms or alternative diagnosis, according to the American Academy of Otolaryngology-Head and Neck Surgery and the Journal of Infection 5, 6